logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Abarelix CAS 183552-38-7

Abarelix CAS 183552-38-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 183552-38-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
183552-38-7
Appearance::
Solid
Molecular Formula::
C72H95ClN14O14
Molecular Weight::
1416.06000
EINECS NO::
NA
MDL NO::
MFCD17011970
CAS NO::
183552-38-7
Appearance::
Solid
Molecular Formula::
C72H95ClN14O14
Molecular Weight::
1416.06000
EINECS NO::
NA
MDL NO::
MFCD17011970
Abarelix CAS 183552-38-7

Product Description:

Product Name: Abarelix CAS NO: 183552-38-7


Synonyms:

Abarelix Acetate;

Ac-DNal-DCpa-DPal-Ser-NαMeTyr-DAsp-Leu-Ilys-Pro-DAl-NH2;


Chemical & Physical Properties:

Appearance: Solid

Assay :≥99.00%

Density: 1.286g/cm3

Boiling Point: 1688.4℃ at 760mmHg

Flash Point: 974.9℃

Refractive Index: 1.601

Vapor Pressure: 0mmHg at 25℃


Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the amount of t-estosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.It was originally marketed by Praecis Pharmaceuticals as Plenaxis, and is now marketed by Speciality European Pharma in Germany after receiving a marketing authorisation in 2005.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.